Results 241 to 250 of about 145,206 (314)

The Relationship Between Quality of Discharge Teaching and Oral Nutritional Supplementation Adherence in Postoperative Patients With Gastric Cancer: A Chain Mediated Role of Readiness for Hospital Discharge and Medication Beliefs

open access: yesJournal of Clinical Nursing, Volume 35, Issue 2, Page 685-697, February 2026.
ABSTRACT Aim We aimed to elucidate the underlying mechanisms influencing Oral nutritional supplementation (ONS) adherence in postoperative patients with gastric cancer (GC) by developing a structural equation model. Background ONS represents a cost‐effective nutritional intervention for postoperative patients with GC, with its efficacy largely ...
Fang Shen   +5 more
wiley   +1 more source

Surgical treatment of perforated gastric tumors. [PDF]

open access: yesWorld J Gastrointest Surg
Aguiar MFF   +4 more
europepmc   +1 more source

A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients

open access: green, 2019
Yang Lp   +12 more
openalex   +1 more source

Deep Learning Model for Predicting Operative Mortality After Total Gastrectomy: Analysis of the Japanese National Clinical Database (NCD)

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 1, Page 67-76, January 2026.
Deep learning‐based prediction model for operative mortality using the National Clinical Database (NCD). The model achieved a C‐statistic of 0.74. ABSTRACT Background Radical gastrectomy with lymph node dissection is the primary treatment for gastric cancer.
Ryosuke Fukuyo   +5 more
wiley   +1 more source

Examination of the Resection Margin Involvement after Gastrectomy for Gastric Cancer

open access: diamond, 2013
Takanori Konishi   +9 more
openalex   +2 more sources

Optimal Cutoff Size of Large Borrmann Type III Gastric Cancer: Is 8 cm Accurate in Predicting Survival and Incidence of Peritoneal Metastasis?

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 1, Page 77-86, January 2026.
ABSTRACT Background Large type III gastric cancer (GC) ≥ 8 cm has conventionally been categorized with type IV GC in Japan, leading to alternative treatment strategies such as neoadjuvant chemotherapy and staging laparoscopy (SL). However, whether 8 cm is the correct cutoff remains unclear.
Yutaka Sugita   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy